Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rossmax InternationalROCO:4121 -1.54%55 Days Payable is 80.17 as of Mar. 2026, which is 34% above its 10-year median of 59.67. GuruFocus rates ROCO:4121 with a GF Score™ of 55/100 and a GF Value™ of NT$18.22 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Rossmax International ranks better than 56.55% on this metric.
The historical rank and industry rank for Rossmax International's Days Payable or its related term are showing as below:
ROCO:4121'
s Days Payable Range Over the Past 10 Years
Min: 48.71 Med: 59.67 Max: 81.91
Current: 77.44
During the past 13 years, Rossmax International's highest Days Payable was 81.91. The lowest was 48.71. And the median was 59.67.
ROCO:4121's Days Payable is ranked better than 56.55% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs ROCO:4121: 77.44
Rossmax International Days Payable Historical Data
* Premium members only.
The historical data trend for Rossmax International's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4121 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Rossmax International's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossmax International Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rossmax International's Days Payable distribution charts can be found below:
* The bar in red indicates where Rossmax International's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Rossmax International's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossmax International (ROCO:4121) has a Days Payable of 80.17 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Rossmax International and its competitors. This is 34% above median its historical median of 59.67. Over the past decade, Rossmax International's Days Payable has ranged from 48.71 to 81.91. According to the industry distribution chart, Rossmax International ranks #345 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 43.5%.
Is Rossmax International's Days Payable too high?
Rossmax International's current Days Payable of 80.17 is 34% above median its 10-year median of 59.67. Over the past 10 years, this metric has ranged from a low of 48.71 to a high of 81.91. The Medical Devices & Instruments industry median Days Payable is 67.85. Rossmax International's value of 80.17 is 18.2% above this industry median. Based on the distribution chart, Rossmax International ranks #345 out of 794 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Rossmax International has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossmax International's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rossmax International ranks #345 out of 794 companies for Days Payable. This puts Rossmax International in the upper half of its industry. The industry median Days Payable is 67.85. Rossmax International's value of 80.17 is 18.2% above this benchmark. Historically, Rossmax International's own Days Payable has ranged from 48.71 to 81.91 over the past decade. While the company's 10-year median is 59.67 vs. the industry median of 67.85, Rossmax International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossmax International's current Days Payable of 80.17 is 18.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Rossmax International and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossmax International's current Days Payable is 80.17, which is 34% above median its own 10-year median of 59.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossmax International stock overvalued right now?
Based on GuruFocus' analysis, Rossmax International (ROCO:4121) is currently considered Possible Value Trap. The stock's GF Value™ is NT$18.22, compared to a current price of NT$12.80 — trading 29.7% below its estimated fair value. The current Days Payable is 80.17, which is 34% above median its 10-year median of 59.67 and 18.2% above the Medical Devices & Instruments industry median of 67.85. Rossmax International's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Rossmax International (ROCO:4121), the current Days Payable is 80.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossmax International (ROCO:4121) Overvalued in 2026?
Based on GuruFocus' analysis, Rossmax International stock appears to be undervalued.
The current stock price of NT$12.80 is trading 29.7% below its estimated GF Value™ of NT$18.22.
GuruFocus considers Rossmax International to be Possible Value Trap.
Key valuation signals for ROCO:4121:
Days Payable: 80.17 (34% above median its 10-year median of 59.67)
GF Value™: NT$18.22 vs. price of NT$12.80 (29.7% below fair value)
Industry Position: 18.2% above the Medical Devices & Instruments median (#345 of 794)
No single metric tells the full story. See the ROCO:4121 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossmax International Ltd is mainly engaged in medical equipment manufacturing, wholesale or retail, and the medicine and cosmetics channels. The group has three reportable departments: the medical device department, the retail channel department, and the investment department. The medical device department manufactures various types of medical supplies. The retail channel department is engaged in the retail of cosmetics, medical equipment, food products, and beverages. Geographically, it derives key revenue from the Taiwan region and the rest from Iraq, Algeria, the U.S.A, the U.A.E, Malaysia, Iran, Kazakhstan, South Korea, Norway, Croatia, Tunisia, and Other.
55GF Score
Get the complete analysis for ROCO:4121
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4121 has been successfully added to your 
